text.skipToContent text.skipToNavigation
医薬品

医薬品

Innovative pharmaceutical ingredients for pharmaceutical synthesis and formulation

医薬品

13アイテムが見つかりました。

フィルター
適用されたフィルターすべてクリア

カテゴリ
性状
Sustainable
サンプルリクエスト
要求者の連絡先の詳細
フルネーム
会社
位置
電話番号
仕事用メールアドレス
お届け先の住所

Thank you. Your request has been sent.

Purilex® - Cefalexin Monohydrate Compacted

Purilex Compacted (Cefalexin Monohydrate), granules obtained by means of dry compaction of the crystalline powder without adding any excipients. Granules are produced using green enzymatic technology in a sustainable and environmentally friendly manner. No solvents are used in the process leading to improved smell of the final product wash. This form is suitable for the manufactured of capsules after the addition of excipients such as magnesium stearate. It is a oral broad spectrum cephalosporin white to almost white powder granules with shelf life of 4 years.
Purimox® Powder Extra Dry

Purimox Powder Extra Dry (Amoxicillin Trihydrate),a crystalline powder produced using green enzymatic technology in a sustainable and environmentally friendly manner. No solvents are used in the process leading to improved smell of the product. The product is suitable for the manufacture of mixture with Clavunate potassium/ moisture sensitive formulation. Therapeutic category; oral broad spectrum penicillin. Shelf life minimum of 4 years.
Purimox® Powder

Purimox Powder (Amoxicillin Trihydrate),a crystalline powder produced using green enzymatic technology in a sustainable and environmentally friendly manner. No solvents are used in the process leading to improved smell of the product. The product is suitable for the manufacture of granules for suspension, dry powder mixtures for syrup & tablets. The appropriate excipients should be added. Therapeutic category; oral broad spectrum penicillin. Shelf life minimum of 4 years.
Disintequik MCC 25

Sheffied Tabletting System Disintequik MCC 25 is a co-processed excipient consisting of 75% Alpha monohydrate lactose and 25% Microcrystalline Cellulose (MCC). The processing results in a co-agglomeration compound of the two ingredients, spray dried lactose and MCC, preserving the identity of each component. Prior to processing, both ingredients meet all of the requirements as outlined in the current monographs of the EU, JP and NF. Disintequick MCC 25 reduces raw materials QC Testing, Manufacturing Steps and process validation. A Drug Master File is available. Added benefits include: reduction of blending issues, low dust generation, the avoidance of costly wet granulation processes, improved flowability and content uniformity during compression.
商品数量を更新しました。